Expert Opinion
Start a conversation with your patients with multiple sclerosis (MS) about what matters to them. Broaden your understanding of MS by watching expert-led ECTRIMS and EAN 2021 video clips.
- Gain frontline insights about what patients with MS value from leading MS experts presenting at the ECTRIMS and EAN 2021 satellite symposium
- In videos condensed to save you time, experts discuss treatment goals for patients with MS, targeted B-cell therapy, and what can happen when treatment preferences of patient and healthcare professionals are not aligned
- Learn about treating-to-target in multiple sclerosis (MS), and what it means for experts
- Watch the award winning 'Looking Inward,' a moving account of the clinical meaning of music therapy (MT) for people with MS
Treating-to-target in multiple sclerosis
Learn about treating-to-target in multiple sclerosis (MS), and what it means for experts at the Novartis-sponsored symposium: Treating-to-Target in Multiple Sclerosis: Why, How and When, at ECTRIMS 2021.
- Professor Laura Airas advises on giving patients with MS the right treatment at the right time
- Four video clips, led by Dr Ann Bass, on improving MS outcomes in the era of COVID-19
- Professor Massimo Filippi reveals the hardships of MS for patients and their families, and how new MS treatments can offer them new hope
Join MS experts, Martin Duddy (Chair, Consultant Neurologist, Clinical Director for Neurosciences, Royal Victoria Infirmary, Newcastle upon Tyne, UK), Professor Laura Airas (Professor of Neuroimmunology, University of Turku, Finland), Dr Ann Bass (MS Neurologist, Neurology Center of San Antonio, US), and Professor Massimo Filippi (Professor of Neurology, Universitá Vita-Salute Raffaele, Italy) at ECTRIMS 2021, held in October 2021, for the Novartis-sponsored satellite symposium: Treating to Target in Multiple Sclerosis: Why, How and When.
Targeting MS Pathology: Choosing the right treatment for MS at the right time
Choosing the right treatment for MS at the right time to effectively target MS pathology is a crucial clinical challenge. Professor Laura Airas describes the in vivo profiling of MS patients, which is a developing sub-discipline in MS care. Treatment choices and timing may be improved through the emergence of a new paradigm in MS management based on assessment and monitoring of multiple active pathomechanisms rather than simply clinical presentation. Watch the clips below to enhance your understanding of MS.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Partnering with patients
Start a conversation with your patients with multiple sclerosis (MS) about what matters to them. Broaden your understanding of MS by watching expert-led EAN 2021 video clips.
- Gain frontline insights about what patients with MS value from leading MS experts presenting at the EAN 2021 satellite symposium
- In videos condensed to save you time, experts discuss treatment goals for patients with MS, targeted B-cell therapy, and what can happen when treatment preferences of patient and healthcare professionals are not aligned
- Watch the award-winning Novartis-sponsored 'Looking Inward,' a moving account of the clinical meaning of music therapy (MT) for people with MS
Join MS experts, Ralf Linker (Chair of the Department of Neurology, University of Regensburg), Dr Stephen Yeung (Neurologist and Instructor, Loma Linda University Medical Center) and Colleen Harris (Nurse Practitioner at the University of Calgary) at the 7th EAN Congress, held in June 2021, for the Novartis-supported satellite symposium: partnering with patients at the start of the MS journey: priorities, practicalities and progress.
The video resources in this section, adapted from the Novartis-supported symposium, led by key experts, focus on what matters most to people with MS, and the challenges managing MS during the COVID-19 pandemic.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Holistic approach to multiple sclerosis management
View the award-winning, Novartis-sponsored documentary 'Looking Inward,' a moving account of the clinical meaning of music therapy (MT) for people with multiple sclerosis (MS).
- See how MT can dramatically improve patient motor and cognitive outcomes
- Hear from health care professionals on the effectiveness of MT in the context of MS
- Holistic, or multidisciplinary management of MS addresses the physical, psychological, and social factors that may improve MS symptoms in some patients – MT is a holistic therapy for MS
'Looking Inward', Silver Dolphin Winner in the Corporate Online Media, Web Documentaries Category by Cannes Corporate Media & TV Awards, is a moving account of the clinical value of non-pharmacological interventions, such as MT, for people living with MS. The video includes insights from people with MS, a MT practitioner, neurologist, and rehabilitation physician.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
of interest
are looking at
saved
next event
Developed by EPG Health for Medthority in collaboration with Novartis Pharma AG, with content provided by Novartis Pharma AG. The views presented in the videos are those of the presenters and not necessarily those of the industry sponsor, Novartis Pharma AG. Any data on non-Novartis products are based on publicly available information at the time of content update. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the SmPC or product information approved in your local country. MLR ID: 138452-1